Request the clinical dossier.
Manufacturing documentation, bioactive profile, and protocol guidance. The full technical package, sent directly.
Pioneering the science of regeneration.
Signals the body
already knows how to read.
Hakke manufactures quantified exosome therapeutics under GMP conditions in Japan, engineered for practitioners who need documentation, not just a story.
Cellular messengers,
not cells themselves.
Exosomes are nanoscale vesicles that cells release to carry biological signals to other cells. Repair instructions, not living tissue. That distinction is the entire premise of what we manufacture.
Three formulations, one signalling standard.
Each formulation isolates a different signalling profile, quantified and manufactured to the same standard.
Every vial is manufactured in a Class 100 cleanroom in Japan, under conditions compliant with the Pharmaceutical and Medical Device Act, and quantified before release: 30 billion exosomes per vial, batch after batch.
Who we are.
We manufacture the signalling science behind Hakke's formulations — quantified exosome platforms, documented for the practitioners who use them, not marketed as a promise.